Laurel Wealth Advisors (North Carolina)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.6M | Buy |
|
|||||
|
2025
Q1 | $1.25M | Sell |
|
|||||
|
2024
Q4 | $1.51M | Sell |
|
|||||
|
2024
Q3 | $1.71M | Buy |
|
|||||
|
2024
Q2 | $1.38M | Buy |
|
|||||
|
2024
Q1 | $830K | Buy |
|
|||||
|
2023
Q4 | $382K | Sell |
|
|||||
|
2023
Q3 | $592K | Sell |
|
|||||
|
2023
Q2 | $748K | Sell |
|
|||||
|
2023
Q1 | $881K | Buy |
|
|||||
|
2022
Q4 | $924K | Buy |
|
|||||
|
2022
Q3 | $757K | Hold |
|
|||||
|
2022
Q2 | $906K | Hold |
|
|||||
|
2022
Q1 | $895K | Hold |
|
|||||
|
2021
Q4 | $1.02M | Buy |
|
|||||
|
2021
Q3 | $703K | Buy |
|
|||||
|
2021
Q2 | $565K | Hold |
|
|||||
|
2021
Q1 | $523K | Buy |
|
|||||
|
2020
Q4 | $523K | Buy |
|
|||||
|
2020
Q3 | $478K | Buy |
|
|||||
|
2020
Q2 | $400K | Buy |
|
|||||
|
2020
Q1 | $318K | Buy |
|
|||||
|
2019
Q4 | $378K | Sell |
|
|||||
|
2019
Q3 | $372K | Buy |
|
|||||
|
2019
Q2 | $445K | Buy |
|
|||||
|
2019
Q1 | $406K | Hold |
|
|||||
|
2018
Q4 | $417K | Buy |
|